✦ LIBER ✦

Twelve-Month Outcomes With a Paclitaxel-Eluting Stent Transitioning from Controlled Trials to Clinical Practice (the WISDOM Registry)

✍ Scribed by Alexandre Abizaid; Charles Chan; Yean-Teng Lim; Upendra Kaul; Nakul Sinha; Tejas Patel; Huay-Cheem Tan; Julio Lopez-Cuellar; Efrain Gaxiola; Saligram Ramesh; Alfredo Rodriguez; Mary E. Russell

Book ID: 113443209
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 76 KB
Volume: 98
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.05.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twelve-month clinical outcomes of everol

Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials

✍ Salvatore Cassese; Raffaele Piccolo; Gennaro Galasso; Roberta De Rosa; Federico 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 648 KB

Comparison of Short- (One Month) and Lon

Comparison of Short- (One Month) and Long- (Twelve Months) Term Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents in 293 Consecutive Patients With Diabetes Mellitus (from the RESEARCH and T-SEARCH Registries)

✍ Andrew T.L. Ong; Jiro Aoki; Carlos A.G. van Mieghem; Gaston A. Rodriguez Granill 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 171 KB

TCT-264: Twelve-month Clinical Outcomes

TCT-264: Twelve-month Clinical Outcomes After Coronary Stenting with the Genous™ Bio-engineered R Stent™ in Patients with a Bifurcation Lesion From the e-HEALING Registry

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

LONGTERM CARDIOVASCULAR OUTCOME AFTER BA

LONGTERM CARDIOVASCULAR OUTCOME AFTER BARE-METAL STENTING POST-DILATED WITH THE PACLITAXEL-ELUTING BALLOON IS NON-INFERIOR COMPARED TO THE XIENCE V DRUG-ELUTING STENT: 2-YEAR CLINICAL DATA FROM THE OCTOPUS TRIAL

✍ Otto, Sylvia; Nitsche, Kristina; Gassdorf, Johannes; Janiak, Florian; Jung, Chri 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 461 KB

COMPARISON OF A PACLITAXEL ELUTING STENT

COMPARISON OF A PACLITAXEL ELUTING STENT WITH BIODEGRADABLE POLYMER AND GLYCOLIX COATING VERSUS BARE METAL STENT DESIGN: FIRST PRESENTATION OF 9 MONTHS CLINICAL AND ANGIOGRAPHIC OUTCOME OF THE RANDOMIZED, MULTICENTER AND CONTROLLED EUCATAX TRIAL(NCT00825279).

✍ Rodriguez, Alfredo E.; Vigo, Federico C.; Delacasa, Alejandro; Bernardi, Victor; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB